Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953 - PB 91 of 2013

Link to law: https://www.comlaw.gov.au/Details/F2013L02167

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 91 of 2013
 
Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953
_____________________________________________________________________
 
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated                                          18 December 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953.
(2)                This Instrument may also be cited as PB 91 of 2013.
2              Commencement                                                        
                This instrument commences on 1 January 2014.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]   Schedule 4, omit entry for Aprepitant
[2]   Schedule 4, after entry for Budesonide with Eformoterol in the form Powder for oral inhalation in breath actuated device containing budesonide
200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose,
120 doses
(a)           insert in the column headed “Form (strength, type, size, etc.)”:
 
Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2
(b)           omit:

 
Pressurised inhalation containing budesonide 50 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses, 2

 
Pressurised inhalation containing budesonide 100 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses, 2

 
Pressurised inhalation containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses, 2

[3]   Schedule 4, omit entry for Leflunomide
[4]   Schedule 4, entry for Miconazole
omit:
 
Lotion containing miconazole nitrate 20 mg per mL, 30 g